Read this company snapshot
Daily valuation snapshot
Enlivex Ltd. Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.25
- Market capitalization (USD)
- $5,056,782.11
- Price / earnings (TTM)
- 0
- Price / book
- 0
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ENLV in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ENLV in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Ness Ziona, Israel.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing ENLV with another company.
| Daily close (USD) | $0.25 |
| Market capitalization (USD) | $5,056,782.11 |
| Price / earnings (TTM) | 0 |
| Price / book | 0 |
No matching rows. Clear the filter to see all records.
Read ENLV's valuation metrics
Company size
Enlivex Ltd. Ordinary Shares's recorded market capitalization is $5,056,782.11. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
ENLV's recorded P/E is 0: about $0 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
ENLV's recorded price-to-book ratio is 0. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Enlivex Ltd. Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about ENLV. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ENLV's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.